申请人:Otsuka Pharmaceutical Company, Limited
公开号:EP1553088A1
公开(公告)日:2005-07-13
The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof,
(wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula -CH2RA; X is a halogen atom or a group of the formula -S(O)n-R1) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.
本发明涉及通式(1)代表的1-取代-4-硝基咪唑化合物或其盐、
(其中R为氢原子、低级烷氧基取代的低级烷基、苯基-低级烷氧基取代的低级烷基、氰基取代的低级烷基、苯基-低级烷基(其在苯基环中可有低级烷氧基作为取代基)或式-CH2RA的基团;X为卤素原子或式-S(O)n-R1的基团)及其制备方法。式(1)化合物是一种有用的化合物,可作为合成各种医药和农药的中间体,特别是作为抗结核剂的中间体。